# Friedman Industries Inc: financial statements, quarterly

FRD · Nasdaq · CIK 39092 · [Materials](/sectors/materials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/frd.md) · [Financials](/companies/frd/financials.md) · [Filings](/companies/frd/filings.md) · [Insiders](/companies/frd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/frd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [137](/filings/0001437749-24-025535.md) | [131](/filings/0001437749-24-034552.md) | [116](/filings/0001437749-25-003166.md) | [132 d](/filings/0001437749-25-020219.md) | [115](/filings/0001437749-25-025433.md) | [107](/filings/0001437749-25-034118.md) | [94.1](/filings/0001437749-26-003530.md) | [129 d](/filings/0001437749-25-020219.md) | [135](/filings/0001437749-26-026305.md) | [152](/filings/0001437749-25-034118.md) | [168](/filings/0001437749-26-003530.md) | [240](/filings/0001437749-26-026305.md) |
| Cost of revenue | $m | [121](/filings/0001437749-23-023695.md) | [125](/filings/0001437749-23-031962.md) | [106](/filings/0001437749-24-004167.md) | [140 d](/filings/0001437749-25-020219.md) | [116](/filings/0001437749-25-025433.md) | [107](/filings/0001437749-25-034118.md) | not reported | not reported | [128](/filings/0001437749-26-026305.md) | [150](/filings/0001437749-25-034118.md) | [164](/filings/0001437749-26-003530.md) | [219](/filings/0001437749-26-026305.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [5.9](/filings/0001437749-24-025535.md) | [4.7](/filings/0001437749-24-034552.md) | [4.2](/filings/0001437749-25-003166.md) | [6.1 d](/filings/0001437749-25-020219.md) | [4.5](/filings/0001437749-25-025433.md) | [3.9](/filings/0001437749-25-034118.md) | [3.9](/filings/0001437749-26-003530.md) | [3.8 d](/filings/0001437749-25-020219.md) | [5.5](/filings/0001437749-26-026305.md) | [6.3](/filings/0001437749-25-034118.md) | [7.2](/filings/0001437749-26-003530.md) | [10.8](/filings/0001437749-26-026305.md) |
| Operating income | $m | [10.4](/filings/0001437749-24-025535.md) | [1.1](/filings/0001437749-24-034552.md) | [6.2](/filings/0001437749-25-003166.md) | [6.9 d](/filings/0001437749-25-020219.md) | [(1.4)](/filings/0001437749-25-025433.md) | [(0.2)](/filings/0001437749-25-034118.md) | [(1.2)](/filings/0001437749-26-003530.md) | [5.9 d](/filings/0001437749-25-020219.md) | [7.0](/filings/0001437749-26-026305.md) | [2.9](/filings/0001437749-25-034118.md) | [3.9](/filings/0001437749-26-003530.md) | [21.0](/filings/0001437749-26-026305.md) |
| Interest expense | $m | [0.5](/filings/0001437749-24-025535.md) | [0.8](/filings/0001437749-24-034552.md) | [0.8](/filings/0001437749-25-003166.md) | [0.9 d](/filings/0001437749-25-020219.md) | [0.7](/filings/0001437749-25-025433.md) | [0.9](/filings/0001437749-25-034118.md) | [0.6](/filings/0001437749-26-003530.md) | [0.8 d](/filings/0001437749-25-020219.md) | [0.7](/filings/0001437749-26-026305.md) | [0.8](/filings/0001437749-25-034118.md) | [1.3](/filings/0001437749-26-003530.md) | [1.2](/filings/0001437749-26-026305.md) |
| Income tax | $m | [2.6](/filings/0001437749-24-025535.md) | [1.1](/filings/0001437749-24-034552.md) | [0.1](/filings/0001437749-25-003166.md) | [2.2 d](/filings/0001437749-25-020219.md) | [0.7](/filings/0001437749-25-025433.md) | [(0.2)](/filings/0001437749-25-034118.md) | [(0.4)](/filings/0001437749-26-003530.md) | [1.5 d](/filings/0001437749-25-020219.md) | [1.6](/filings/0001437749-26-026305.md) | [0.7](/filings/0001437749-25-034118.md) | [1.0](/filings/0001437749-26-003530.md) | [4.2](/filings/0001437749-26-026305.md) |
| Net income | $m | [7.7](/filings/0001437749-25-003166.md) | [3.5](/filings/0001437749-25-003166.md) | [1.2](/filings/0001437749-25-003166.md) | [5.0 d](/filings/0001437749-25-020219.md) | [2.6](/filings/0001437749-26-003530.md) | [(0.7)](/filings/0001437749-26-003530.md) | [(1.2)](/filings/0001437749-26-003530.md) | [5.3 d](/filings/0001437749-25-020219.md) | [5.0](/filings/0001437749-26-026305.md) | [2.2](/filings/0001437749-26-003530.md) | [3.0](/filings/0001437749-26-003530.md) | [12.8](/filings/0001437749-26-026305.md) |
| Diluted EPS | $ per share | [1.04](/filings/0001437749-24-025535.md) | [0.48](/filings/0001437749-24-034552.md) | [0.16](/filings/0001437749-25-003166.md) | not reported | [0.37](/filings/0001437749-25-025433.md) | [(0.10)](/filings/0001437749-25-034118.md) | [(0.17)](/filings/0001437749-26-003530.md) | not reported | [0.71](/filings/0001437749-26-026305.md) | [0.32](/filings/0001437749-25-034118.md) | [0.43](/filings/0001437749-26-003530.md) | [1.79](/filings/0001437749-26-026305.md) |
| Basic EPS | $ per share | [1.04](/filings/0001437749-24-025535.md) | [0.48](/filings/0001437749-24-034552.md) | [0.16](/filings/0001437749-25-003166.md) | not reported | [0.37](/filings/0001437749-25-025433.md) | [(0.10)](/filings/0001437749-25-034118.md) | [(0.17)](/filings/0001437749-26-003530.md) | not reported | [0.71](/filings/0001437749-26-026305.md) | [0.32](/filings/0001437749-25-034118.md) | [0.43](/filings/0001437749-26-003530.md) | [1.79](/filings/0001437749-26-026305.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | period not labelled (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.2](/filings/0001437749-23-031962.md) | [4.0](/filings/0001437749-24-004167.md) | [2.9](/filings/0001437749-25-020219.md) | [4.1](/filings/0001437749-24-025535.md) | [2.5](/filings/0001437749-24-034552.md) | [1.1](/filings/0001437749-25-003166.md) | [3.7](/filings/0001437749-26-003530.md) | [2.1](/filings/0001437749-25-025433.md) | [4.6](/filings/0001437749-25-034118.md) | [3.0](/filings/0001437749-26-003530.md) | [2.5](/filings/0001437749-26-026305.md) | [5.0](/filings/0001437749-26-026305.md) |
| Current assets | $m | [165](/filings/0001437749-23-031962.md) | [171](/filings/0001437749-24-004167.md) | [170](/filings/0001437749-25-020219.md) | [162](/filings/0001437749-24-025535.md) | [148](/filings/0001437749-24-034552.md) | [149](/filings/0001437749-25-003166.md) | [166](/filings/0001437749-26-003530.md) | [158](/filings/0001437749-25-025433.md) | [231](/filings/0001437749-25-034118.md) | [231](/filings/0001437749-26-003530.md) | [257](/filings/0001437749-26-026305.md) | [291](/filings/0001437749-26-026305.md) |
| Total assets | $m | [222](/filings/0001437749-23-031962.md) | [229](/filings/0001437749-24-004167.md) | [230](/filings/0001437749-25-020219.md) | [223](/filings/0001437749-24-025535.md) | [209](/filings/0001437749-24-034552.md) | [210](/filings/0001437749-25-003166.md) | [227](/filings/0001437749-26-003530.md) | [219](/filings/0001437749-25-025433.md) | [311](/filings/0001437749-25-034118.md) | [312](/filings/0001437749-26-003530.md) | [337](/filings/0001437749-26-026305.md) | [373](/filings/0001437749-26-026305.md) |
| Current liabilities | $m | [35.3](/filings/0001437749-23-031962.md) | [54.6](/filings/0001437749-24-004167.md) | [54.1](/filings/0001437749-25-020219.md) | [38.8](/filings/0001437749-24-025535.md) | [36.4](/filings/0001437749-24-034552.md) | [42.3](/filings/0001437749-25-003166.md) | [38.3](/filings/0001437749-26-003530.md) | [40.5](/filings/0001437749-25-025433.md) | [71.4](/filings/0001437749-25-034118.md) | [64.4](/filings/0001437749-26-003530.md) | [76.1](/filings/0001437749-26-026305.md) | [100](/filings/0001437749-26-026305.md) |
| Total liabilities | $m | [95.3](/filings/0001437749-23-031962.md) | [106](/filings/0001437749-24-004167.md) | [103](/filings/0001437749-25-020219.md) | [93.1](/filings/0001437749-24-025535.md) | [80.4](/filings/0001437749-24-034552.md) | [82.9](/filings/0001437749-25-003166.md) | [94.4](/filings/0001437749-26-003530.md) | [81.8](/filings/0001437749-25-025433.md) | [172](/filings/0001437749-25-034118.md) | [170](/filings/0001437749-26-003530.md) | [185](/filings/0001437749-26-026305.md) | [209](/filings/0001437749-26-026305.md) |
| Shareholders' equity | $m | [127](/filings/0001437749-25-003166.md) | [123](/filings/0001437749-25-003166.md) | [127](/filings/0001437749-26-003530.md) | [130](/filings/0001437749-26-003530.md) | [129](/filings/0001437749-26-003530.md) | [127](/filings/0001437749-26-003530.md) | [132](/filings/0001437749-26-026305.md) | [137](/filings/0001437749-26-026305.md) | [139](/filings/0001437749-26-003530.md) | [142](/filings/0001437749-26-003530.md) | [151](/filings/0001437749-26-026305.md) | [164](/filings/0001437749-26-026305.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.6)](/filings/0001437749-24-025535.md) | [(15.7) d](/filings/0001437749-24-034552.md) | [21.3 d](/filings/0001437749-25-003166.md) | [4.0 d](/filings/0001437749-25-020219.md) | [(6.1)](/filings/0001437749-25-025433.md) | [10.8 d](/filings/0001437749-25-034118.md) | [2.7 d](/filings/0001437749-26-003530.md) | [(11.8) d](/filings/0001437749-25-020219.md) | [15.5](/filings/0001437749-26-026305.md) | [0.4 d](/filings/0001437749-25-034118.md) | [(4.7) d](/filings/0001437749-26-003530.md) | [7.3](/filings/0001437749-26-026305.md) |
| Capital expenditure | $m | [0.5](/filings/0001437749-24-025535.md) | [2.4 d](/filings/0001437749-24-034552.md) | [1.9 d](/filings/0001437749-25-003166.md) | [1.0 d](/filings/0001437749-25-020219.md) | [1.1](/filings/0001437749-25-025433.md) | [0.8 d](/filings/0001437749-25-034118.md) | [1.1 d](/filings/0001437749-26-003530.md) | [1.0 d](/filings/0001437749-25-020219.md) | [1.8](/filings/0001437749-26-026305.md) | [2.5 d](/filings/0001437749-25-034118.md) | [1.6 d](/filings/0001437749-26-003530.md) | [2.2](/filings/0001437749-26-026305.md) |
| Dividends paid | $m | [0.1](/filings/0001437749-24-025535.md) | [0.1 d](/filings/0001437749-24-034552.md) | [0.1 d](/filings/0001437749-25-003166.md) | [0.1 d](/filings/0001437749-25-020219.md) | [0.3](/filings/0001437749-25-025433.md) | [0.3 d](/filings/0001437749-25-034118.md) | [0.3 d](/filings/0001437749-26-003530.md) | [0.3 d](/filings/0001437749-25-020219.md) | [0.3](/filings/0001437749-26-026305.md) | [0.3 d](/filings/0001437749-25-034118.md) | [0.3 d](/filings/0001437749-26-003530.md) | [0.3](/filings/0001437749-26-026305.md) |
| Share repurchases | $m | [0.0](/filings/0001437749-24-025535.md) | [0.0 d](/filings/0001437749-24-034552.md) | [5.1 d](/filings/0001437749-25-003166.md) | [0.0 d](/filings/0001437749-25-020219.md) | [0.1](/filings/0001437749-25-025433.md) | [0.0 d](/filings/0001437749-25-034118.md) | [0.0 d](/filings/0001437749-26-003530.md) | [0.0 d](/filings/0001437749-25-020219.md) | [0.0](/filings/0001437749-26-026305.md) | [(0.0) d](/filings/0001437749-25-034118.md) | [0.0 d](/filings/0001437749-26-003530.md) | [0.1](/filings/0001437749-26-026305.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2021 (2020-06-30) | Q2 FY2021 (2020-09-30) | Q3 FY2021 (2020-12-31) | Q1 FY2022 (2021-06-30) | Q2 FY2022 (2021-09-30) | Q3 FY2022 (2021-12-31) | Q1 FY2023 (2022-06-30) | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,080](/filings/0001437749-21-020720.md) | [7,068](/filings/0001437749-21-027176.md) | [7,040](/filings/0001437749-22-003280.md) | [6,585](/filings/0001437749-22-024042.md) | [6,585](/filings/0001437749-22-028342.md) | [6,610](/filings/0001437749-23-002900.md) | [7,071](/filings/0001437749-23-023695.md) | [7,243](/filings/0001437749-23-031962.md) | [7,275](/filings/0001437749-24-004167.md) | [7,289](/filings/0001437749-23-023695.md) | [7,289](/filings/0001437749-23-031962.md) | [7,245](/filings/0001437749-24-004167.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,212,791 at 2026-08-06, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026305.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.